NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) — Reason:Rosen Law Firm, a global investor rights law firm, is reminding those who purchased Humanigen, Inc. (NASDAQ:HGEN) securities between May 16, 2020 and July 12, 2022, inclusive, the “Class Action Period”. October 25, 2022this is importantDeadline for Lead Plaintiff?
That means:If you purchased Humanigen Securities during the Class Period, you may be entitled to compensation and a contingency fee arrangement without out-of-pocket expenses or disbursements.
What to do next:To participate in the Humanigen fundraiser, please visit https://rosenlegal.com/submit-form/?case_id=8376 or call toll-free 866-767-3653 or email [email protected] or [email protected] Contact Attorney Phillip Kim to learn more about class action lawsuits. The firm has filed a class action lawsuit. If you wish to appear as lead plaintiff, you must do so Before October 25, 2022apply to the court. The lead plaintiff is the representative party conducting litigation on behalf of the other group members.
Why choose ROSEN LAW:Investors are encouraged to select attorneys who are qualified and have a proven track record of serving in senior positions. Frequently, the litigating law firm does not have the appropriate experience, resources, or serious recognition from peers.Many of these law firms do not actually participate in securities class action lawsuits, but merely act as intermediaries, referring or working with clients to law firms that actually file lawsuits.Be sure to choose your legal counsel wisely. The law firm Rosen serves investors worldwide, with a focus on securities class action lawsuits and shareholder derivatives lawsuits. Law firm Rosen has successfully settled the largest securities class action lawsuit to date against a Chinese company. Rosen Law Firm was named the #1 law firm by ISS Securities Class Action Services in 2017 for the number of securities class action settlements. Since 2013, the law firm Rosen…
Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/10/26/2542079/673/zh-hant/%E4%BB%8A%E5%A4%A9%E6%98%AF-HGEN-%E9%9B%86%E9%AB%94%E8%A8%B4%E8%A8%9F%E7%9A%84%E6%9C%80%E5%BE%8C%E6%9C%9F%E9%99%90-%E5%85%A8%E7%90%83%E9%A0%82%E7%B4%9A%E5%BE%8B%E5%B8%AB%E4%BA%8B%E5%8B%99%E6%89%80-ROSEN-%E5%BB%BA%E8%AD%B0%E6%90%8D%E5%A4%B1%E8%B6%85%E9%81%8E-10-%E8%90%AC%E7%BE%8E%E5%85%83%E7%9A%84-Humanigen-Inc-%E6%8A%95%E8%B3%87%E8%80%85%E5%9C%A8-10-%E6%9C%88-25-%E6%97%A5%E8%AD%89%E5%88%B8%E9%9B%86%E9%AB%94%E8%A8%B4%E8%A8%9F%E7%9A%84%E9%87%8D%E8%A6%81%E6%88%AA%E6%AD%A2%E6%97%A5%E6%9C%9F%E5%89%8D%E8%81%98%E8%AB%8B%E5%BE%8B%E5%B8%AB.html
